Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

This publication has 16 references indexed in Scilit:

• Ep-CAM LEVELS IN PROSTATIC ADENOCARCINOMA AND PROSTATIC INTRAEPITHELIAL NEOPLASIA
  Journal of Urology, 1999
• Estimates of the worldwide mortality from 25 cancers in 1990
  International Journal of Cancer, 1999
• Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target?
  Journal of Clinical Pathology, 1999
• Detection of Surface Antigen 17-1A in Breast and Colorectal Cancer
  Hybridoma, 1999
• Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A
  Cancer Immunology, Immunotherapy, 1996
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
  The Lancet, 1995
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report
  Annals of Internal Medicine, 1995
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
  The Lancet, 1994
• Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
  Investigational New Drugs, 1992
• The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
  International Journal of Cancer, 1986